Vedere
Cambridge, US · 2 known investors
Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.
Investors · 2
Frequently asked questions
- What does Vedere do?
- Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.
- Who are Vedere's investors?
- Vedere's investors include Mission Bay Capital, Mission Biocapital.
- Where is Vedere headquartered?
- Vedere is headquartered in Cambridge, US.